Immunotherapy in NSCLC Patients With Brain and Leptomeningeal Metastases

Immunotherapy has now been integrated as a treatment strategy for most patients with non-small cell lung cancer (NSCLC). However, the pivotal clinical trials that demonstrated its impressive efficacy often did not include patients with active, untreated brain metastases or leptomeningeal carcinomato...

Descripción completa

Detalles Bibliográficos
Autores principales: Pierret, Thomas, Giaj-Levra, Niccolò, Toffart, Anne-Claire, Alongi, Filippo, Moro-Sibilot, Denis, Gobbini, Elisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9039308/
https://www.ncbi.nlm.nih.gov/pubmed/35494085
http://dx.doi.org/10.3389/fonc.2022.787080

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9039308/
https://www.ncbi.nlm.nih.gov/pubmed/35494085
http://dx.doi.org/10.3389/fonc.2022.787080

Ejemplares similares